Company
Chemomab Therapeutics Ltd. (CMMB)
Standardized SEC financial data for Chemomab Therapeutics Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001534248 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-72.9%
Free cash flow
-$11.1M
Current ratio
9.08×
EPS (diluted)
$0.02
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of revenue | — | $3.3M | $5.1M | $4.4M | $2.5M | $2.3M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.7M | $15.2M | $13.6M | $9.4M | $14.3M | $10.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$5.2M | -$12.4M | -$20.4M | -$23.6M | -$15.4M | -$11.1M |
| Capital expenditures |
Get CMMB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CMMB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CMMB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"